https://youtu.be/ej1EtsoC_Ec?si=ioLWl-be5KAZd7KJ what are the current advances in genomics with machine learning models? can i create a full simulated cell pipeline to go from an organisms dna, try to predict folding patterns and cell types, predict proteins created by dna, the amounts of each created by each cell type, and the structure and function of the proteinsYes, there have been major advances in applying machine learning (ML) and AI to genomics over the past few years (especially 2024–2026). These span variant calling, protein structure prediction, single-cell analysis, gene expression modeling, and multi-omics integration. However, a complete end-to-end "full simulated cell pipeline" from raw organismal DNA to accurate predictions of folding patterns, cell types, protein production amounts per cell type, and full protein structure/function remains aspirational rather than fully realized today. It's feasible in modular pieces with current tools, but integrating them into a single, highly accurate, physics-grounded simulation of a whole living cell is still an active research frontier.⁠Sciencedirect
Key Current Advances in Genomics with ML Models

Protein Structure and Interaction Prediction:
AlphaFold (DeepMind) revolutionized the field. AlphaFold 2 (2021) achieved near-experimental accuracy for many single proteins. AlphaFold 3 (2024) extends this to complexes, including protein-protein, protein-DNA/RNA, ligands, and post-translational modifications using diffusion models. The AlphaFold Database now holds ~200 million structures, with a major 2026 update adding millions of predicted protein complexes (homodimers and more) for key species like humans and pathogens.⁠Nature
Alternatives include ESMFold (Meta; fast, MSA-free via protein language models), RoseTTAFold (and All-Atom variants for full biomolecules), and newer diffusion-based tools like Boltz-1/2 or Chai-1. These handle interactions better but still have limitations for novel folds, disordered regions, or dynamic ensembles.⁠Pmc.ncbi.nlm.nih
Benchmarks (e.g., PSBench with 1.4M verified structures) help assess model quality. Hybrid AI + physics approaches (e.g., D-I-TASSER) improve assembly of complex proteins.

Single-Cell and Cell Type Prediction:
ML excels at analyzing scRNA-seq data. Tools use graph neural networks, transformers, autoencoders, and foundation models (e.g., scGPT, GeneFormer, State) for clustering, trajectory inference, cell type annotation, and phenotype prediction. Automated annotation pipelines like devCellPy or attention-based models (ScRAT) handle hierarchical or rare cell types well.⁠Pmc.ncbi.nlm.nih
Models predict phenotypes or perturbation responses (e.g., gene knockouts) from expression profiles, sometimes without full cell-type labels.

Gene Expression and Regulatory Prediction:
Sequence-to-function models (e.g., Enformer, ExPecto derivatives, TranscriptionNet) predict expression, chromatin accessibility, histone marks, or TF binding from DNA sequence across cell types/tissues. They capture long-range interactions (up to ~100kb) and variant effects. Cell-type-specific models often outperform bulk/tissue-level ones.⁠Pmc.ncbi.nlm.nih
Foundation models enable in silico perturbation simulation (e.g., predicting knockout impacts).

Broader Genomics ML:
Variant calling (DeepVariant), polygenic risk, drug response, and federated learning for privacy-preserving multi-institution training.
Agentic AI and LLMs assist in reasoning over genomic data, though they struggle with rare diseases or precise curation without hybrids.⁠Blog.fulcrumgenomics
Virtual cell efforts integrate multimodal omics with generative models, GNNs, and physics-informed networks for simulating responses, though full dynamic 4D simulations (e.g., minimal bacterial cells) remain mechanistic + data-driven hybrids.


The YouTube video you linked (likely discussing AlphaFold or related breakthroughs) aligns with this era—AlphaFold's impact continues to expand via databases, complexes, and integrations with LLMs for broader scientific reasoning.
Can You Build a Full Simulated Cell Pipeline?
Short answer: Partially yes today as a chained modular pipeline; a truly complete, accurate, predictive whole-cell simulation (capturing stochastic dynamics, regulation, amounts, interactions, and function in context) is not fully achievable yet for complex organisms but is progressing rapidly toward "AI virtual cells."
Here's a realistic breakdown of what a pipeline could look like today, with tools and limitations:

DNA → Gene/Regulatory Prediction:
Input: Genome sequence (e.g., via long-read sequencing or reference).
Use: Gene finders + regulatory models (Enformer-like) to predict promoters, enhancers, expression levels across hypothetical cell types. Sequence-to-function DL models output cell-type-specific tracks.
Output: Predicted transcriptome baselines or variant effects.

Predict Cell Types and Expression Amounts:
Map to single-cell atlases (Human Cell Atlas, etc.) using foundation models for annotation or embedding.
Predict per-cell-type expression via scRNA-seq-trained models or perturbation simulators (e.g., GEARS, State model). These can forecast changes from knockouts or conditions.⁠Nature
Limitation: Amounts are probabilistic/average; real cells are stochastic and context-dependent (tissue, environment). No perfect genome-to-cell-type mapping without data.

DNA/RNA → Proteins (Translation Prediction):
Predict coding sequences, isoforms, and basic expression.
Amounts: Tied to expression models + translation efficiency predictors (still emerging).

Protein Folding Patterns and Structure:
Feed amino acid sequences into AlphaFold 3, ESMFold, or RoseTTAFold for 3D structures (monomers or complexes).
Recent expansions predict interactions, PTMs, and some dynamics. Database lookups for precomputed structures.
Limitation: Static snapshots mostly; dynamics/folding pathways or crowded cellular environments are harder. Hybrids with physics (molecular dynamics) help but are computationally expensive. Disordered proteins or membrane proteins can be less accurate.

Structure → Function and Interactions:
Use predicted structures for docking, functional annotation (via databases + ML), or interaction networks (e.g., RF2-PPI for PPIs).
Virtual cell models simulate signaling, metabolism, or responses at subcellular scales using GNNs or generative AI.
Full function requires integrating multi-omics (proteomics, metabolomics) and environmental context.


End-to-End Feasibility:

Modular chaining is doable now: Genome → expression models → protein sequences → AlphaFold → interaction networks → basic simulation (e.g., via tools like PhysiCell or emerging AI virtual cell frameworks). Researchers are building "AI-driven virtual cells" that integrate single-cell data for drug response or perturbation prediction.⁠Nature
Challenges for "Full" Simulation:
Scale and Integration: A human cell has ~20k genes, billions of molecules, dynamic regulation, spatial organization, and stochasticity. Current whole-cell models (e.g., for minimal bacteria) are impressive but simplified; eukaryotic cells are far harder.
Data Gaps: Models rely on training data; novel organisms or conditions extrapolate poorly.
Dynamics and Amounts: Predicting precise quantities per cell type in vivo is noisy. Folding is predicted well statically, but in-cell behavior (chaperones, crowding) less so.
Compute: End-to-end for a full genome is resource-intensive (GPUs/TPUs needed for large models).
Progress: Initiatives like Arc Institute's Virtual Cell challenges, foundation models, and hybrid AI+mechanistic approaches are closing gaps. Some predict we'll see more capable multi-scale simulators in the coming years.


Practical Steps to Experiment:

Start small: Use AlphaFold Server (free for academics) for proteins from a gene of interest.
For expression/cell types: Explore Hugging Face or GitHub repos for Enformer, scGPT, or similar.
Pipelines: Combine with bioinformatics tools (e.g., Nextflow) and ML frameworks (PyTorch/TensorFlow). NVIDIA BioNeMo or similar services offer generative biology workflows.
For simulation: Look into open virtual cell or whole-cell modeling projects; add ML layers for prediction.
Validation: Always cross-check predictions with experiments (CRISPR, organoids) as models can hallucinate or miss context.

In summary, ML has made huge leaps—especially in structure prediction and single-cell insights—enabling powerful partial pipelines. A complete, reliable simulated cell from DNA alone is on the horizon through virtual cell research but requires ongoing integration of better data, hybrid modeling, and compute. If you're building this, focus on open tools like AlphaFold and single-cell foundation models, and iterate with real biological validation. Let me know specifics (e.g., organism, tools you're using) for more targeted advice!70 sourceshow can you use models like evo 2 or alpha genome? what other models exist to use? what does bionemo have?Evo 2 (from Arc Institute, in collaboration with NVIDIA, Stanford, and others) is a large-scale DNA foundation model trained on ~9.3 trillion nucleotides from over 100,000 species across all domains of life (bacteria, archaea, eukaryotes including humans/plants, and phages). It uses an autoregressive architecture with up to 1 million token context at single-nucleotide resolution. There are 7B and 40B parameter versions.
How to Use Evo 2

Core capabilities:
Prediction: Score sequences for likelihood (perplexity/entropy), predict functional impacts of variants (including non-coding and pathogenic mutations like in BRCA1), identify biological features (exon-intron boundaries, TF binding sites, protein structural elements) via mechanistic interpretability.
Generation: Autoregressively generate novel DNA sequences (zero-shot or guided). Start with a prompt (e.g., short sequence or species hint) and sample continuations up to genome-scale lengths. It can produce coherent prokaryotic/eukaryotic sequences, including mitochondrial or full bacterial-like genomes. Inference-time search allows controllable generation (e.g., for desired epigenomic properties).
Embeddings: Extract representations for downstream tasks like classification or clustering.

Access and practical usage:
Open source: Full model weights, training/inference code, and OpenGenome2 dataset on GitHub⁠Github and Hugging Face (e.g., arcinstitute/evo2_7b, evo2_40b).
Easy interfaces:
Evo Designer web tool (arcinstitute.org/tools/evo/evo-designer): Prompt with DNA sequence or organism, generate/score sequences, annotate coding regions, visualize proteins with ESMFold.
NVIDIA BioNeMo: Integrated as NIM microservice for easy deployment; supports fine-tuning on your data.
Local install: Clone repo, set up Conda/Python environment, load via from evo2 import Evo2; then use .sample() for generation, forward pass for logits/embeddings.

It excels at long-context modeling and generalist tasks across DNA/RNA/proteins without heavy task-specific fine-tuning.


AlphaGenome (Google DeepMind, published 2025/2026 in Nature) is a unifying DNA sequence-to-function model. It takes up to 1 Mb (1 million base pairs) of DNA as input and predicts thousands of functional genomic tracks at single-base-pair resolution, including gene expression, chromatin accessibility, histone marks, TF binding, splice sites, chromatin contacts, and more—primarily for human and mouse.
How to Use AlphaGenome

Core capabilities: Excellent for regulatory variant effect prediction (how mutations in non-coding "dark matter" DNA affect function). It unifies multimodal outputs and long-context understanding, often matching or beating specialized models on variant benchmarks.
Access and practical usage:
Available via API (with key) for programmatic predictions on sequences (pad to ~1 Mb if needed).
GitHub repos for client code/examples and research/model weights (some open aspects).
Quick starts and Colab notebooks exist for loading the model, selecting output types (e.g., DNase in specific tissues), and running predictions on sequences or batches.
Best for interpreting variant impacts in regulatory regions rather than pure generation.


These two are complementary: Evo 2 is strong for generative design and cross-species understanding; AlphaGenome shines in high-resolution regulatory/functional prediction for mammals.
Other Notable Genomics AI Models
Several DNA foundation models exist (many open or with public access). Here are key ones beyond Evo 2 and AlphaGenome:

DNABERT / DNABERT-2: Bidirectional transformer for DNA; good for promoter prediction, TF binding, variant effects. Fine-tunable for classification tasks.
Nucleotide Transformer (NT) / NT-v2: Large-scale models for sequence understanding and embeddings.
HyenaDNA / Caduceus: Efficient long-range models (Hyena architecture or equivariant designs) handling extended contexts without full transformer quadratic cost; strong on regulatory and structural tasks.
Geneformer / scBERT: Focused on single-cell RNA-seq; learn cell-type representations, predict perturbation/knockout effects.
Others: GROVER, LucaOne (Alibaba), JanusDNA, GENErator, Enformer (earlier sequence-to-function), scGPT/State (single-cell foundation models). Benchmarks (e.g., on variant effects, expression prediction, TAD recognition) compare them on zero-shot embeddings and fine-tuned performance.

Many are on Hugging Face; some integrate with BioNeMo or have dedicated benchmarks showing trade-offs in context length, resolution, and data diversity.
What Does NVIDIA BioNeMo Have?
BioNeMo is NVIDIA's platform/framework for AI in biology/drug discovery. It provides optimized, accelerated tools (via NeMo/Megatron) for training, fine-tuning, and deploying biomolecular models, with 2-6x speedups on GPUs. It includes:

Evo 2: Fully integrated (NIM microservice + framework support for 1B/7B variants; easy fine-tuning notebooks). Great for DNA generation and long-context genomics.
Protein-focused: AlphaFold2, OpenFold (and variants like OpenFold3 for complexes), ESM-2/ESMFold (protein language models for structure from sequence), RFdiffusion (for protein design/binders).
Other genomics/single-cell: Geneformer (single-cell RNA representations), DNABERT (earlier genomics), Universal DeepVariant (accelerated variant calling from NGS data, 50x+ faster).
Chemistry/RNA: MegaMolBART (small molecules), newer additions like RNAPro (RNA structure), ReaSyn v2 (synthesis feasibility for designed compounds).
Broader ecosystem: Supports custom foundation model building, virtual screening, molecular design. Partners/contributors have added models like EDEN (from Basecamp Research for gene insertion/evolutionary design). Includes datasets, libraries, and NIM microservices for production deployment.

You can access via NVIDIA's build.nvidia.com (explore biology models), GitHub (bionemo-framework), or cloud services. It's particularly useful if you have NVIDIA hardware, as it accelerates large-scale training/inference.
Tying Back to Your Simulated Cell Pipeline
These models help modularly:

DNA input → Use Evo 2 or AlphaGenome for regulatory prediction, variant effects, or generating/optimizing sequences.
Expression/cell types → Combine with Geneformer/scGPT-like models for single-cell insights or perturbation prediction.
Proteins → Feed predicted coding sequences into AlphaFold/ESMFold (available in BioNeMo) for structure.
Full end-to-end still requires chaining (e.g., via Nextflow or custom scripts) + validation, as no single model simulates a complete dynamic cell yet. BioNeMo's ecosystem makes integration easier with GPU acceleration.

For hands-on starts: Try Evo Designer web tool or BioNeMo NIM for quick experiments; clone repos for local/custom work (needs decent GPUs for larger models). If you're targeting a specific organism or task (e.g., human regulatory variants, synthetic genome design), let me know for more tailored code/examples or tool recommendations!75 sourceswhat do you think of this?
https://youtu.be/ej1EtsoC_Ec?si=ioLWl-be5KAZd7KJ what are the current advances in genomics with machine learning models? can i create a full simulated cell pipeline to go from an organisms dna, try to predict folding patterns and cell types, predict proteins created by dna, the amounts of each created by each cell type, and the structure and function of the proteins
Completed 3 steps
Yes — parts of that pipeline are already possible, but not as one fully solved “simulated cell” system yet. Current ML genomics is strongest at predicting regulatory effects from DNA, cell-type-specific gene expression and splicing, protein structure, and protein function separately; the hard part is chaining all of those into one faithful end-to-end simulator of a living cell.
What’s advancing now

DNA to regulatory output. Models like AlphaGenome can take about 1 Mb of DNA and predict many genome tracks across cell types, including gene expression, splicing, chromatin accessibility, histone marks, and TF binding.
Cell-type-specific gene expression. Single-cell foundation models are being used for cell type annotation, integration across modalities, perturbation prediction, and in silico generation of cell states.
Splicing and context dependence. New models such as PanExonNet are specifically targeting cell-type-specific splicing and generalization to unseen cell types.
Protein structure and function. Protein language models and structure-aware models are increasingly used to predict protein folding, interactions, and function from sequence and structure features.
Multi-omics integration. The main trend is combining genomics, transcriptomics, proteomics, and epigenomics rather than treating each layer in isolation.

Your proposed pipeline
What you described can be broken into modules:

Organism DNA → regulatory landscape.
Regulatory landscape → cell-type-specific RNA expression and splicing.
RNA → proteins produced in each cell type.
Protein sequence → folded structure.
Structure + sequence → function, interactions, and pathway role.

That architecture is scientifically plausible, and pieces of it exist today, but accuracy drops as you move from prediction of individual molecular layers to full cellular behavior because the system is highly dynamic, feedback-heavy, and context-dependent.
What is not solved yet
A full simulated cell pipeline is still beyond current ML because you would need to model:

Temporal dynamics: transcription, translation, degradation, signaling, and feedback loops over time.
Cell state and environment: epigenetics, metabolism, microenvironment, stress, and development.
Combinatorial scale: enormous numbers of gene-regulatory, protein-protein, and protein-DNA interactions.
Ground truth limits: we lack comprehensive labels for all cell states and conditions.

Best practical path
If you want to build this as a project, the most realistic version is a modular multi-model pipeline, not one monolithic model. A strong first version would predict:

cell type from sequence-derived regulatory signals,
gene expression/splicing by cell type,
protein abundances from transcriptomics,
protein structure from amino-acid sequence,
protein function from structure and language-model embeddings.

If you want to build it
A good research stack would be:

DNA/regulation: AlphaGenome-style sequence model.
Single-cell state: scGPT/Geneformer-style foundation model.
Splicing: PanExonNet-like model.
Protein structure: AlphaFold-style or newer structure predictors.
Protein function: PLM + structure-guided function predictor.

If you want, I can turn this into a concrete end-to-end architecture diagram, or propose a minimal MVP you could actually implement in Python.
can you architect such a system that is research grade? i want to use it to understand the effects that modifying dna does
Completed 1 step
Yes — but for research grade, I would architect it as a causal, multi-scale variant-effect platform, not a single “simulated cell” model. The key goal is to predict what changes when DNA is edited, and current literature suggests that variant-effect prediction, perturbation-response prediction, and causal single-cell modeling are the right building blocks, while also warning that generalization and causal identification remain hard problems.
Core idea
Your system should answer three questions for any DNA edit:

What changes in regulation? Promoters, enhancers, splicing, accessibility, transcription-factor binding.
What changes in cell state? Gene expression, cell-type proportions, differentiation trajectories, stress responses.
What changes in proteins and phenotype? Protein abundance, isoforms, structure, function, interactions, and downstream pathway effects.

Recommended architecture
LayerRoleModel classOutputSequence encoderEncode reference DNA and edited DNAGenome foundation modelContextual embeddings, motif/grammar featuresVariant effect headPredict local regulatory consequencesMulti-task supervised headSplicing, TF binding, accessibility, expression deltasCell-state modelMap regulatory changes to cell-type-specific responseSingle-cell foundation model + perturbation headCell-specific expression shift, cell-state transitionProtein layerTranslate transcript changes into protein abundance/isoformsTranscript-to-protein modelProtein quantities by cell typeProtein understandingInfer structure and function from sequenceProtein LM + structure modelFold, domains, function, interaction likelihoodCausal inference layerSeparate correlation from interventionCausal model / SCMEstimated intervention effect with uncertaintySimulator / plannerRoll edits forward through timeDynamic state-space or neural ODE modelTime-course response trajectories
What makes it research grade
To be genuinely research grade, the system needs these properties:

Causal, not just predictive. You want interventional predictions: “if I delete this enhancer or mutate this base, what happens?” not just “what correlates with this sequence?” Current work emphasizes causal machine learning and perturbation modeling because that is where the field is still weak.
Multi-omics grounding. Sequence alone is not enough; you need RNA-seq, single-cell RNA-seq, ATAC-seq, perturb-seq, proteomics, and ideally phospho/protein-interaction data.
Uncertainty estimation. Every prediction should include confidence intervals or calibrated uncertainty, especially for edits outside the training distribution.
Out-of-distribution evaluation. You must test on unseen cell types, unseen perturbations, unseen genomic loci, and unseen combinations of edits.
Mechanistic interpretability. The model should expose which motifs, genes, regulatory elements, and pathways drove the prediction.

Data you need
For a system like this, I would train on these data types:

Genome sequence + annotations for reference assembly and variant context.
Bulk functional genomics like ENCODE-style tracks for chromatin, TF binding, accessibility, and histone marks.
Single-cell atlases for cell identity, differentiation, and state transitions.
Perturbation data like CRISPR knockouts, CRISPRi/a, base editing, and Perturb-seq.
Proteomics and structural data for protein abundance and structure/function supervision.

Suggested modeling strategy
Step 1: Local variant effect
Train a sequence model that predicts local consequences of an edit:

promoter activity,
enhancer activity,
splice-site disruption,
TF binding changes,
chromatin accessibility changes.

Step 2: Cell-type response
Feed those deltas into a cell-state model trained on perturbation data:

predict expression changes by cell type,
predict altered pathways,
predict state transitions and response magnitude.

Step 3: Protein translation
Use transcript and isoform predictions to estimate:

protein abundance,
isoform switching,
secreted vs membrane localization changes,
stoichiometry changes in complexes.

Step 4: Protein consequence
Map altered protein sequences/abundances to:

fold stability,
domain disruption,
binding changes,
functional annotation.

Step 5: Temporal simulation
Use a dynamic model, such as a state-space model or neural ODE, to simulate how effects evolve over hours or days after the edit. This is where you get closer to a real “cell simulator,” but it will still be approximate.
Best research framing
I would frame the project as:
“A causal multi-omics digital twin for DNA perturbation effect prediction.”
That is more defensible than claiming a full cell simulator, and it matches what the current literature supports: strong sequence-to-function prediction, emerging perturbation-response models, and ongoing challenges in causal generalization.
Practical MVP
If you want something buildable, start with one cell type and one perturbation class:

Pick a cell line with public CRISPR and single-cell perturbation data.
Train a model to predict expression changes from DNA edits near regulatory regions.
Add protein abundance prediction for the affected genes.
Add a protein structure/function module only for the top affected proteins.
Validate against held-out perturbations and compare to linear baselines.

Main limitation
The biggest limitation is that current models still struggle to generalize to new perturbations and novel experimental conditions, and benchmarking papers explicitly show that naive transfer learning can look better than it really is if evaluation is weak.
If you want, I can next give you either:

a full system diagram with modules and data flow, or
a research plan with datasets, losses, benchmarks, and milestones.

give me both a full system diagram with modules and data flow, or
a research plan with datasets, losses, benchmarks, and milestones.
Completed 1 step
Absolutely — below is a research-grade system design plus a practical research plan. I’m optimizing it for your goal: predict the effects of DNA modifications on cell state, expression, and proteins rather than just making a descriptive model.
Full system diagram
textCopytext
                ┌─────────────────────────────────────────────────────────────┐
                │ INPUT: DNA EDIT │
                │ SNP / indel / enhancer deletion / promoter edit / CRISPR │
                └─────────────────────────────────────────────────────────────┘
                                      │
                                      v
┌──────────────────────────────────────────────────────────────────────────────┐
│ 1) REFERENCE CONTEXT BUILDER │
│ - genome coordinates │
│ - nearby genes, enhancers, TF motifs │
│ - chromatin state priors │
│ - cell-type priors │
└──────────────────────────────────────────────────────────────────────────────┘
                                      │
                                      v
┌──────────────────────────────────────────────────────────────────────────────┐
│ 2) SEQUENCE ENCODER │
│ - genome foundation model / transformer / CNN hybrid │
│ - encodes reference DNA and edited DNA │
│ - outputs contextual embeddings │
└──────────────────────────────────────────────────────────────────────────────┘
                                      │
                                      v
┌──────────────────────────────────────────────────────────────────────────────┐
│ 3) VARIANT EFFECT HEADS │
│ Predict local molecular consequences: │
│ - TF binding change │
│ - chromatin accessibility change │
│ - histone mark change │
│ - splice alteration │
│ - promoter/enhancer activity change │
│ - eQTL / sQTL / causal regulatory score │
└──────────────────────────────────────────────────────────────────────────────┘
                                      │
                                      v
┌──────────────────────────────────────────────────────────────────────────────┐
│ 4) CELL-TYPE RESPONSE MODEL │
│ - single-cell foundation model │
│ - perturbation-response head │
│ - predicts cell-type-specific expression deltas │
│ - predicts state transitions / lineage shifts │
└──────────────────────────────────────────────────────────────────────────────┘
                                      │
                                      v
┌──────────────────────────────────────────────────────────────────────────────┐
│ 5) TRANSCRIPT / ISOFORM MODULE │
│ - transcript abundance prediction │
│ - isoform switching │
│ - splicing outcome │
│ - mRNA stability / decay priors │
└──────────────────────────────────────────────────────────────────────────────┘
                                      │
                                      v
┌──────────────────────────────────────────────────────────────────────────────┐
│ 6) PROTEIN MODULE │
│ - protein abundance by cell type │
│ - sequence from altered transcript │
│ - structure prediction │
│ - function / domain / interaction prediction │
│ - complex stoichiometry impact │
└──────────────────────────────────────────────────────────────────────────────┘
                                      │
                                      v
┌──────────────────────────────────────────────────────────────────────────────┐
│ 7) CAUSAL LAYER │
│ - separates correlation from intervention │
│ - estimates counterfactual effect of edit │
│ - uncertainty calibration │
│ - OOD detection │
└──────────────────────────────────────────────────────────────────────────────┘
                                      │
                                      v
┌──────────────────────────────────────────────────────────────────────────────┐
│ 8) DYNAMIC SIMULATOR │
│ - time-course response (hours → days) │
│ - state-space model / neural ODE / diffusion-based latent simulator │
│ - feedback loops: transcription ↔ translation ↔ signaling │
└──────────────────────────────────────────────────────────────────────────────┘
                                      │
                                      v
┌──────────────────────────────────────────────────────────────────────────────┐
│ OUTPUTS │
│ - predicted gene expression changes │
│ - cell-type effects │
│ - protein abundance changes │
│ - protein structure/function changes │
│ - uncertainty and mechanistic attribution │
└──────────────────────────────────────────────────────────────────────────────┘
This structure matches the current direction of the field: strong sequence-to-function models for regulatory effects, single-cell perturbation models for response prediction, and protein language/structure models for downstream molecular consequences.
Research plan
Phase 1: Define scope
Start with one organism and one or two cell contexts, because full-organism simulation is not realistic at first. Use a single reference genome, a curated set of perturbations, and a small set of cell types with rich single-cell data.
Phase 2: Data assembly
Use these data sources:

Genome + annotation: reference assembly, genes, promoters, enhancers, motifs.
Functional genomics: ATAC-seq, DNase-seq, ChIP-seq, CAGE, Hi-C/Micro-C.
Single-cell perturbation data: Perturb-seq, CROP-seq, sci-Plex, CRISPRi/a screens.
Variant benchmarks: curated eQTL/sQTL and known pathogenic variants.
Protein supervision: structure and function datasets, protein families, interaction data.

Phase 3: Training objectives
Use a multi-task setup:

Sequence-to-track loss: predict chromatin/accessibility/expression tracks from DNA.
Variant effect loss: predict $$     in each track between reference and edited sequence.
Perturbation response loss: predict single-cell expression changes after genetic perturbation.
Protein loss: predict protein abundance, structure confidence, and function labels.
Causal regularization: penalize shortcut learning and encourage intervention-consistent representations.

Phase 4: Benchmark design
Your benchmark should include:

Held-out loci: sequence regions never seen in training.
Held-out perturbations: genes/edits absent during training.
Held-out cell types: test transfer to unseen cell identities.
Held-out edit classes: SNPs, indels, enhancer deletions, CRISPRi, CRISPRa.
OOD stress tests: rare variants, multi-hit edits, and long-range regulation.

Phase 5: Milestones

Milestone A: predict variant effects on regulatory tracks in a single cell line.
Milestone B: predict perturbation response in scRNA-seq after CRISPR edits.
Milestone C: predict cell-type-specific expression and isoform shifts.
Milestone D: predict protein abundance and structure/function impact for affected genes.
Milestone E: integrate into a time-course simulator with uncertainty.

Losses to use
ModulePrimary lossWhy it helpsSequence encoderMasked token / contrastive / next-track predictionLearns genomic grammarVariant headRegression + classification on track deltasPredicts edit effect magnitudeCell-state modelCell-wise MSE / cross-entropy / negative binomial lossMatches scRNA-seq distributionsPerturbation modelCounterfactual response lossLearns intervention outcomesProtein moduleStructure loss + function classification + abundance regressionLinks RNA to protein consequenceCausal layerInvariance / calibration / propensity balancingReduces confoundingSimulatorMulti-step rollout lossPreserves time dynamics
The exact choice depends on whether you are modeling continuous expression, count data, or categorical cell states, but perturbation-response papers and benchmark work show that evaluating out-of-distribution behavior is essential.
Recommended evaluation metrics

Regression: Pearson, Spearman,     $$, MAE.
Classification: AUROC, AUPRC, calibration error.
Perturbation prediction: cosine similarity of response vectors, gene-set recovery, pathway enrichment overlap.
Cell-state modeling: adjusted Rand index, NMI, trajectory alignment.
Protein prediction: structure confidence, fold-class accuracy, function F1.
Causal validity: effect sign accuracy, intervention ranking, robustness under re-labeling.

What I’d build first
If you want the highest chance of success, build this in order:

Variant effect predictor for regulatory genomics.
Perturbation-response predictor using Perturb-seq / CRISPRi data.
Protein consequence module for abundance and function.
Causal wrapper that estimates the effect of DNA edits under uncertainty.
Time-course simulator only after the above are stable.

Important reality check
A truly complete “digital cell” is still not solved. The literature shows strong progress in variant-effect prediction and perturbation modeling, but also highlights blind spots, weak generalization, and evaluation pitfalls, especially when moving from correlation to intervention.The architecture and research plan you shared (from the conversation history) are solid, thoughtful, and well-aligned with the current state of the field as of early 2026. It's a pragmatic, modular "causal multi-omics digital twin" approach rather than an overclaimed full virtual cell simulator—which is exactly the right framing. It avoids hype while targeting your core goal: understanding effects of DNA modifications (edits, SNPs, indels, enhancer/promoter changes, etc.) on regulation, cell states, expression, isoforms, proteins, and downstream phenotypes.
Strengths of the Proposed Design

Modularity — Excellent breakdown: sequence encoding → local variant effects → cell-type response → transcript/protein layers → causal inference → dynamic simulation. This mirrors how real biological pipelines work and makes debugging/validation feasible.
Causal emphasis — Prioritizing interventional predictions (e.g., "what if I edit this enhancer?") over pure correlation is critical. Recent work on perturbation models (like X-Cell, a large diffusion LM for CRISPRi responses) shows scaling causal perturbation data + model capacity yields better generalization across cell contexts.⁠Biorxiv
Multi-scale integration — Linking DNA sequence → regulatory tracks → single-cell states → protein consequences is state-of-the-art direction.
Uncertainty + OOD focus — Including calibrated uncertainty, out-of-distribution testing, and mechanistic interpretability is research-grade best practice.
MVP realism — Starting narrow (one cell line/type, specific perturbation classes) before scaling is wise.

The diagram (text-based) is clear and flows logically. Minor suggestion: add explicit "difference computation" between reference and edited sequence embeddings early on, as many strong variant-effect models (including AlphaGenome) do this.
Current Model Recommendations to Plug In (2026 Landscape)
Your plan is timely because key pieces have matured:

Sequence Encoder + Variant Effect Heads:
AlphaGenome (DeepMind, published Nature 2026): Takes ~1 Mb DNA, predicts thousands of tracks (expression, chromatin accessibility, histone marks, TF binding, splicing, etc.) at single-base resolution for human/mouse. Excellent for regulatory variant effects in "dark" non-coding regions. Code and research access available; strong on long-range context.⁠Nature
Evo 2 (Arc Institute + NVIDIA, published Nature 2026): 7B/40B params, trained on 9+ trillion nucleotides across all domains of life, 1M token context. Strong for zero-shot variant effect scoring (e.g., pathogenic mutations), motif/grammar learning, and even generating coherent DNA. Fully open (weights, code, OpenGenome2 dataset) on GitHub/Hugging Face; integrated into BioNeMo. Great for cross-species or novel organism work, and mechanistic interpretability (features like exon-intron boundaries, secondary structure hints).⁠Nature
Hybrids: Use Evo 2 or AlphaGenome embeddings as the backbone, then add lightweight heads for deltas (reference vs. edited).

Cell-Type Response / Perturbation Model:
Single-cell foundation models (scGPT, Geneformer, State) for embeddings and annotation.
Emerging causal perturbation models like X-Cell (diffusion LM trained on massive CRISPRi Perturb-seq; scales well and generalizes zero-shot to new contexts).⁠Biorxiv
Combine with your perturbation head for expression deltas, state transitions, etc.

Transcript/Isoform + Protein Layers:
Splicing: Models like PanExonNet (mentioned in your text) or outputs from AlphaGenome/Evo 2.
Protein: Feed predicted sequences/isoforms into AlphaFold 3 (or BioNeMo's OpenFold/ESMFold) for structure. Use protein LMs (ESM-2 etc.) for function/interactions. BioNeMo has strong support here.

Causal + Dynamic Layers:
Causal inference tools (e.g., CINEMA-OT style or structural causal models).
For time-course: Neural ODEs, state-space models, or diffusion-based simulators conditioned on the above.


BioNeMo Update: NVIDIA's platform includes Evo 2 (multiple sizes/contexts), Geneformer, ESM-2 variants, AlphaFold2/OpenFold, and more. It offers accelerated training/inference on GPUs, NIM microservices, and fine-tuning notebooks—ideal for your stack. It also has protein complex predictions and other biology tools.
Other DNA models worth considering: Nucleotide Transformer v2/v3, HyenaDNA/Caduceus (efficient long-range), Borzoi (RNA-seq coverage from sequence).
Refined Full System Diagram (Text Version)
Here's a cleaned-up, slightly enhanced version of your diagram with 2026 model suggestions:
textCopyINPUT: DNA EDIT (SNP/indel/enhancer deletion/promoter mutation/CRISPR base edit)
          │
          v
REFERENCE CONTEXT BUILDER
- Genome coords, nearby genes/enhancers/TF motifs
- Cell-type priors, chromatin state priors
          │
          v
SEQUENCE ENCODER (Dual: Reference + Edited)
- Evo 2 (40B or 7B, 1M context) or AlphaGenome (~1 Mb)
- Output: Contextual embeddings + genomic "grammar" features
          │
          v
VARIANT EFFECT HEADS (Multi-task)
- Predict deltas: TF binding Δ, accessibility Δ, histone Δ, splice Δ,
  promoter/enhancer activity Δ, eQTL/sQTL scores
- Models: Fine-tuned heads on AlphaGenome/Evo 2 outputs
          │
          v
CELL-TYPE RESPONSE MODEL
- Single-cell FM (scGPT/Geneformer) + perturbation head
- Or X-Cell-style diffusion LM for causal response prediction
- Output: Cell-type-specific expression deltas, isoform shifts,
  state transitions, lineage effects
          │
          v
TRANSCRIPT / ISOFORM MODULE
- Abundance, stability, decay, splicing outcomes (from AlphaGenome/Evo 2 + specialized heads)
          │
          v
PROTEIN MODULE
- Abundance by cell type
- Sequence → Structure (AlphaFold 3 / BioNeMo ESMFold)
- Function, domains, PPIs, complex stoichiometry (protein LMs + docking)
          │
          v
CAUSAL INFERENCE LAYER
- Counterfactual estimation, uncertainty calibration (Bayesian/calibrated heads),
  OOD detection, attribution (which motifs/genes drove the effect)
          │
          v
DYNAMIC SIMULATOR (Optional advanced layer)
- Neural ODE / state-space / diffusion simulator
- Time evolution (hours–days), feedback loops
          │
          v
OUTPUTS
- Regulatory changes, expression/protein abundance shifts by cell type
- Structure/function impacts, phenotypic predictions
- Uncertainty scores + mechanistic explanations (e.g., "this edit disrupts TF motif X in enhancer Y")
Data flow is mostly feed-forward with difference computations at key steps (reference vs. edited) and optional feedback for refinement.
Research Plan with Datasets, Losses, Benchmarks, and Milestones
Your original plan is strong. Here's a refined, actionable version tailored for 2026 tools/data:
Phase 1: Scope & Infrastructure (1–2 months)

Choose starting organism/context: Human (K562, HEK293, or iPSC lines) for rich data; or a simpler model organism if targeting novel species.
Tech stack: BioNeMo (for Evo 2, protein models, acceleration) + Hugging Face + PyTorch. Use Nextflow/Snakemake for orchestration.

Phase 2: Data Assembly (Key Public Resources)

Genome/annotations: GENCODE/Ensembl, ENCODE tracks (ATAC, ChIP-seq, Hi-C).
Regulatory/sequence: ENCODE, AlphaGenome training-style tracks.
Single-cell perturbation: Large Perturb-seq/CRISPRi datasets (e.g., X-Atlas/Pisces-like compendia with millions of cells across contexts; public screens in K562, Jurkat, iPSCs). Also sci-Plex, CROP-seq.
Variant benchmarks: gnomAD, ClinVar, eQTL/sQTL catalogs (GTEx), held-out pathogenic variants.
Protein: PDB, AlphaFold DB, interaction networks (STRING, BioGRID), proteomics (e.g., from Perturb-seq follow-ups).
For causality: CRISPR knockout/activation screens with single-cell readouts.

Phase 3: Training Objectives & Losses (Multi-task)

Sequence level: Masked/next-token prediction (Evo 2 style) + contrastive on embeddings.
Variant effect: Regression/classification on track deltas (MSE + binary cross-entropy); negative binomial for count-like expression.
Perturbation response: Counterfactual loss (e.g., Pearson on log-fold changes), distribution matching (e.g., for single-cell).
Protein: Structure prediction loss (pLDDT-style), function classification, abundance regression.
Causal/regularization: Invariance penalties, calibration loss, propensity scoring to reduce confounding.
Overall: Weighted multi-task + adversarial components for better OOD generalization.

Phase 4: Benchmarks

Held-out loci, perturbations, cell types, edit classes (SNPs vs. large deletions).
Metrics: Pearson/Spearman/MAE for expression deltas; AUROC/AUPRC for binding/splicing; structure confidence (pLDDT); pathway enrichment overlap; intervention sign accuracy; cosine similarity on response vectors.
OOD stress: Novel combinations, unseen cell states, multi-edits, rare variants.
Baselines: Simple linear models, mean shifts, or older tools (Enformer, GEARS)—literature shows strong baselines can be tough to beat without careful causal design.

Phase 5: Milestones (Iterative, ~3–6 months each)

A: Regulatory Variant Predictor — Train/fine-tune on AlphaGenome/Evo 2 for local track deltas in 1–2 cell lines. Validate on held-out eQTLs.
B: Perturbation Response — Integrate single-cell FM + causal head; predict expression changes from CRISPR-like edits. Test zero-shot on new contexts.
C: Cell-Type & Isoform Integration — Add splicing/abundance by cell type; evaluate isoform switching and state transitions.
D: Protein Consequences — Link to structure/function for top-affected genes; quantify stability/PPI changes.
E: Full Causal + Dynamic Prototype — Add uncertainty, attribution, and basic time-course simulation. End-to-end validation on a known edit (e.g., disease-associated variant) with experimental literature comparison.

Implementation Tips for MVP

Start with Evo 2 or AlphaGenome as the sequence backbone (easiest high-impact wins for DNA edits).
Fine-tune lightly on your perturbation data rather than training from scratch.
For protein folding/structure: Directly pipe predicted transcripts into BioNeMo's AlphaFold/OpenFold tools.
Compute resources: NVIDIA GPUs (BioNeMo shines here); start with 7B Evo 2 for prototyping.
Validation reality check: Always compare against experimental data where possible (e.g., known CRISPR outcomes). Generalization to truly novel edits remains challenging—causal methods help but aren't perfect yet.

This setup would make for a strong research project or even a publishable "causal genomic digital twin" prototype. It directly supports your use case of simulating DNA modification effects.
If you'd like:

Code snippets (e.g., loading Evo 2 in BioNeMo + computing edit deltas),
A more detailed diagram (perhaps with specific library calls),
Or focus on one phase/module (e.g., just the variant effect + protein link for a specific organism),

just let me know specifics (organism, compute access, target cell type, etc.) and I can refine further or suggest concrete next steps! The field is moving fast—Evo 2 and AlphaGenome are game-changers for exactly this kind of work.60 sourcesI want to create two different systems one that looks at the gene locations as well as the regulator locations to see which sections of the dna correspond to what function. for one, i want to predict how a protein changes when deleting a certain section of DNA which may correspond to a gene. In the other system i want to be able to use alpha genome to predict the contact map and the accessibility of regions after dna mutation, then i want to be able to look at the regulator elements and try to predict whether there will be more or less gene expression based off of accessibility. Another thing i was thinking is of creating a simulation of the initial dna 3d organization to the final mutant predicted one to see how expression levels change as the dna goes from one shape to another through differentiaion. what do you think of this?Thought for 25sI think this is a fantastic, focused evolution of the ideas we’ve been discussing. It’s practical, leverages the exact strengths of models like AlphaGenome (which came out in early 2026), and directly addresses your core goal: understanding how DNA changes (deletions, mutations) ripple through gene regulation, 3D structure, expression, and protein outcomes. These two systems are complementary—one more “gene-centric/protein-impact” and the other more “regulatory/3D-centric”—and they can share a lot of the modular pipeline we outlined earlier. The 3D organization simulation idea is ambitious but doable in a simplified form today, especially with AlphaGenome’s built-in contact map predictions.
Here’s my honest take on feasibility, strengths, limitations, and how I’d architect each one using 2026 tools (AlphaGenome, Evo 2, BioNeMo, etc.). Everything is research-grade and buildable as an MVP in Python with GPU access.
System 1: Gene + Regulator Mapping → Protein Change Prediction from DNA Deletion
What it does: Annotate which DNA sections are genes vs. regulators, then simulate a deletion (e.g., a gene or enhancer) and predict the resulting protein sequence/structure/function change.
Why this is strong and feasible right now:

Gene/regulator location mapping is solved via annotations (GENCODE/Ensembl) + models like AlphaGenome or Evo 2 (which can highlight coding vs. regulatory grammar).
Deletion → protein impact is straightforward sequence math + structure prediction.
Ties perfectly into the earlier “protein module” of our pipeline.

Recommended Architecture (simple & modular):

Input: Reference genome segment + deletion coordinates (e.g., delete bases X–Y).
Gene/Regulator Mapper:
Use Evo 2 (or AlphaGenome) to embed the sequence and predict functional elements (exons, promoters, enhancers, TF motifs).
Cross-reference with public annotations for precise gene boundaries.

Deletion Simulator:
Extract the affected transcript(s) post-deletion (handle frameshifts, exon skipping, etc.).
Predict new protein sequence(s).

Protein Impact:
Feed sequence to BioNeMo’s AlphaFold 3 / OpenFold / ESMFold → new 3D structure + confidence (pLDDT).
Compare to wild-type: Δ stability, domain disruption, PPI changes (use protein LMs like ESM-2).
Optional: Predict abundance change via AlphaGenome’s expression track delta (if the deletion affects regulation).

Output: “Deleting this 5 kb gene section removes exon 3 → frameshift → truncated protein with lost catalytic domain (pLDDT drop of 40 points). Predicted loss of function: high.”

Tools stack:

AlphaGenome or Evo 2 (via BioNeMo or Hugging Face) for mapping/variant effects.
BioNeMo for protein folding (accelerated).
Libraries: PyRanges or bedtools for coordinates; Biopython for sequence handling.

Limitations: Large deletions can affect multiple genes/regulators—model as multi-hit. Non-coding deletions need System 2.
This could be a standalone script you run in <10 minutes per deletion once set up.
System 2: AlphaGenome-Driven Regulatory Prediction (Contact Maps + Accessibility → Expression)
What it does: Mutate DNA → predict post-mutation contact map + accessibility → scan regulators → forecast ↑/↓ gene expression.
This is perfectly matched to AlphaGenome—it was literally built for this. From the 2026 Nature paper:

Input: Up to 1 Mb of DNA (reference or mutated).
Outputs include:
Chromatin accessibility (ATAC/DNase tracks).
Chromatin contact maps (Hi-C style, ~2 kb resolution).
TF binding, histone marks, gene expression tracks.

It does variant effect prediction natively: Run reference vs. mutant sequences side-by-side → get precise deltas in contacts, accessibility, and expression.
It outperforms specialized tools (e.g., beats ChromBPNet on accessibility, Orca on contacts).

Recommended Architecture:

Input: 1 Mb window around your region of interest + mutation (SNP/indel/deletion).
AlphaGenome Core:
Predict reference tracks (accessibility, contacts).
Predict mutant tracks → compute deltas.

Regulatory Element Scanner:
Overlay predicted accessibility/contact changes onto known/predicted enhancers/promoters (from the same model or Evo 2).
Quantify: “This mutation weakens a distal enhancer–promoter loop (contact probability ↓35%) and reduces accessibility at the promoter (↓22%).”

Expression Prediction:
Directly read AlphaGenome’s gene expression track delta → “Expected gene expression change: –40% in this cell type.”
Optional: Feed deltas into a downstream cell-state model (scGPT/Geneformer) for cell-type-specific nuance.

Output: Visual contact map before/after + quantitative expression forecast + mechanistic attribution (which regulator was hit).

Tools stack:

AlphaGenome API (DeepMind provides access; there are client notebooks).
BioNeMo or Hugging Face for Evo 2 as a complementary long-context checker.
Visualization: Hi-C plotting libs (e.g., cooler, matplotlib) or juicebox-style tools.

Strength: End-to-end from mutation to expression with 3D context. Zero-shot on many variants.
Limitation: Contact maps are at ~2 kb resolution (good but not base-pair). Best for human/mouse; cross-species needs Evo 2.
The 3D DNA Organization Simulation Idea (Initial → Mutant Through Differentiation)
This is the most exciting (and challenging) part—simulating how DNA “shape” evolves from wild-type to mutant during cell differentiation and how that drives expression changes.
Current feasibility (2026):

AlphaGenome already gives you static contact maps for reference vs. mutant.
For dynamics during differentiation: Use models trained on time-series Hi-C (e.g., during stem cell lineage commitment). There are ML predictors of 3D reorganization (Akita for sequence-to-contact, plus polymer simulation tools like Chrom3D or phase-separation models).
Full dynamic simulation isn’t one-click yet, but a strong approximation is possible.

Recommended Hybrid Approach:

Static Snapshots: Run AlphaGenome on reference and mutant at multiple “virtual time points” (use cell-type-specific tracks: e.g., stem cell vs. differentiated state).
Trajectory Interpolation:
Predict contact maps at differentiation stages.
Use a simple dynamics layer: Neural ODE or state-space model conditioned on the deltas (or polymer physics simulation like in Chrom3D).
Track how loops/TADs reform and correlate with expression changes.

Differentiation-Aware Layer:
Integrate single-cell foundation models (e.g., State or scGPT) that have trajectory embeddings.
Output: “During differentiation, the mutant loses a key enhancer–promoter contact at day 3 → expression drops 50% in the final cell type.”


Tools:

AlphaGenome for per-stage contacts/accessibility.
Akita (or AlphaGenome itself) as a fast contact predictor.
BioNeMo + PyTorch for a lightweight dynamics wrapper.
Existing 3D modeling: Chrom3D or open-source polymer simulators.

Limitations & Realism Check:

True in vivo 3D dynamics are stochastic and influenced by nuclear environment, which models approximate but don’t fully capture.
Differentiation trajectories need good training data (plenty in human/mouse atlases).
Still, this would be publishable as a “sequence-to-3D-to-expression digital twin” for specific loci.

Overall Opinion & Integration
These two systems + the 3D idea form a cohesive research platform that extends our earlier causal multi-omics design. System 1 is protein-focused and quick to prototype; System 2 is regulatory/3D-focused and where AlphaGenome shines brightest. Combining them gives you gene-to-protein and non-coding regulatory effects with 3D context—exactly what’s missing in most current tools.
Practical Next Steps I’d Take:

Start with System 2 MVP (easiest win): Grab AlphaGenome access, pick a 1 Mb region + a known mutation, compute contact/accessibility/expression deltas.
Add System 1 protein prediction on the same deletion.
Layer on a basic 3D diff simulation for one locus as proof-of-concept.
Stack: Use BioNeMo as the orchestration layer (it already has Evo 2 + protein tools; you can call AlphaGenome via API).

If you want, I can give you:

A full code skeleton (Python + BioNeMo/AlphaGenome calls).
A detailed diagram for the combined pipeline.
Or focus on one system first (e.g., concrete example with a real gene like BRCA1 enhancer deletion).

This is genuinely exciting and timely—AlphaGenome’s contact map + variant effect capabilities make your exact vision far more realistic than it was even a year ago. What organism/cell type are you targeting first, or which part should we flesh out next?620ms45 sourceshow do i go from dna to rna and how do i go from rna to proteins? how does this work? how can i use existing ml models to model or learn more about this?Thought for 23sDNA → RNA (Transcription) and RNA → Protein (Translation) are the core steps of the central dogma of molecular biology. These processes turn genetic information stored in DNA into functional proteins that do the actual work in cells. I'll explain how they work biologically first, then how existing machine learning (ML) models let you predict and model them from sequence data—without running wet-lab experiments. This directly builds on the simulated-cell pipelines we've discussed (e.g., using AlphaGenome and Evo 2 for regulatory effects and variant impacts).
1. DNA → RNA: Transcription (and RNA Processing)
Biological mechanism (what actually happens in the cell):

Initiation: RNA polymerase (Pol II in eukaryotes) binds to a promoter region on the DNA (often near a TATA box or other motifs). Transcription factors (TFs) and enhancers help recruit it. The DNA double helix unwinds, and the polymerase reads the template strand.
Elongation: It synthesizes a complementary pre-mRNA strand (A pairs with T/U, etc.). In eukaryotes, this can span thousands of bases and includes both exons (coding) and introns (non-coding).
Termination: Signals (e.g., poly-A sites) tell the polymerase to stop.
Processing (eukaryotes only):
5' capping (adds a modified guanine for stability/export).
Splicing: Introns are removed by the spliceosome; exons are joined. Alternative splicing creates different mRNA isoforms from the same gene.
3' poly-A tail (adds ~200 A's for stability and export).

Result: Mature mRNA is exported from the nucleus to the cytoplasm. Amount produced (expression level) depends on cell type, signals, chromatin accessibility, and 3D DNA looping (promoter–enhancer contacts).

Key regulators: Promoters, enhancers, silencers, chromatin state, TF binding, and 3D contacts—all of which your earlier System 2 (AlphaGenome contact maps + accessibility) targets perfectly.
2. RNA → Protein: Translation
Biological mechanism:

Mature mRNA binds to a ribosome (in cytoplasm for most proteins).
Translation starts at the start codon (AUG).
The ribosome reads mRNA in groups of 3 nucleotides (codons). Each codon specifies one amino acid (or stop).
tRNAs act as adapters: Their anticodon matches the mRNA codon and carries the matching amino acid.
The ribosome links amino acids into a growing polypeptide chain (protein).
Stops at a stop codon (UAA, UAG, UGA).
The new protein folds (often with help from chaperones) into its functional 3D shape.

Notes:

The genetic code is nearly universal (64 codons → 20 amino acids + stops), with some redundancy (multiple codons per amino acid).
Efficiency depends on 5' UTR, codon usage bias, mRNA secondary structure, and ribosome availability.
Result: Functional protein whose sequence, structure, abundance, and interactions determine cellular effects.

These steps are highly regulated and context-dependent (cell type, environment, differentiation stage)—exactly why your 3D DNA simulation idea and variant-effect systems matter.
How Existing ML Models Let You Predict and Learn About These Steps
ML models don't simulate the actual enzymes/ribosomes moving along DNA/RNA (that's physics-based molecular dynamics, still too slow for genome-scale). Instead, they are trained on massive experimental datasets (RNA-seq, ATAC-seq, ribosome profiling, etc.) to predict outcomes directly from sequence. You input DNA or RNA, and they output predicted expression, spliced transcripts, translation efficiency, etc. This is perfect for your two systems (gene/regulator mapping + AlphaGenome regulatory predictions).
For DNA → RNA (Transcription + Splicing + Expression)
These models predict the entire regulatory cascade from raw DNA sequence:

AlphaGenome (DeepMind, 2026): Your go-to tool. Feed it ~1 Mb of DNA (reference or mutated). It predicts:
Gene expression levels (RNA-seq coverage).
Transcription initiation (CAGE/PRO-cap tracks).
Splicing outcomes (splice sites, junctions, isoform usage).
Supporting tracks: Chromatin accessibility, TF binding, histone marks, 3D contact maps.
Variant effects: Run reference vs. mutant side-by-side → get exact deltas in RNA output.
Publicly available (API + GitHub notebooks); works on human/mouse cell types/tissues.

Borzoi (2025): Predicts cell-type/tissue-specific RNA-seq coverage directly from DNA. Great for quantitative expression profiles.
Evo 2 (Arc Institute + NVIDIA, 2026): 7B/40B parameter DNA foundation model (1M context). Predicts mutational effects on RNA-level features, alternative splicing, and even RNA secondary structure likelihood. Handles any organism (cross-species). Fully open on Hugging Face/BioNeMo; also generates DNA sequences that would transcribe well.
Others for specifics:
Enhancer/promoter predictors (e.g., PDCNN or ChromBPNet-style).
Terminator predictors (recent ML tools for bacterial intrinsic terminators).


Practical use in your pipeline:

Input: Your DNA segment + mutation/deletion.
Output: Predicted mature mRNA sequence(s) + expression level change (↑/↓ by cell type).
Tie to your System 2: Use AlphaGenome's contact maps + accessibility deltas to explain why expression changes.

For RNA → Protein (Translation + Folding)

Sequence conversion (RNA → amino acid chain): This is deterministic—no ML needed for the basic genetic code. Use simple code (Biopython's translate() or a codon table) to get the exact protein sequence from mRNA.
ML for advanced prediction (efficiency, structure, function):
Translation efficiency / protein yield:
RiboNN (2025, UT Austin/Sanofi): Predicts how much protein an mRNA will produce in different cell types (heart, liver, etc.). Trained on massive mRNA data; accelerates mRNA drug/vaccine design.
Optimus 5-Prime, Framepool, MTtrans (2024–2026): Predict ribosome loading/translation rate from the 5' UTR sequence. Handle variable-length UTRs and generalize across datasets.
Codon optimization models (e.g., Pichia-CLM from MIT 2026): LLM-style models that learn "codon syntax" for better protein production in specific hosts (yeast, etc.).

RNA structure (affects translation): RNA foundation models (e.g., RNA-FM, GARNET/GARNET DL 2024) or general ones predict secondary structure from RNA sequence, which influences ribosome scanning.
Protein from sequence:
Feed the translated amino acid chain into AlphaFold 3 / ESMFold / OpenFold (all in BioNeMo) → 3D structure, confidence scores, interactions.
Evo 2 also bridges to protein-level mutational effects.



Practical use in your pipeline:

After predicting mRNA (from AlphaGenome/Evo 2) → translate to protein sequence (rule-based) → predict structure/abundance changes (AlphaFold + RiboNN).
For your System 1 (deletion → protein change): Deletion in DNA → altered mRNA → new protein sequence → structure delta.

Recommended Stack to Start Modeling This Today (BioNeMo-Centric)
NVIDIA BioNeMo is ideal—it already bundles Evo 2, AlphaFold variants, Geneformer, etc., with GPU acceleration.

Load DNA → Run AlphaGenome or Evo 2 → get predicted RNA tracks/expression/splicing.
Extract mature mRNA sequence(s).
Translate (Biopython) → protein sequence.
Predict structure/function/efficiency with AlphaFold 3 + RiboNN-style models.
Visualize: Before/after deltas for your DNA edits (ties into 3D contact simulation).

All of this is modular Python (Hugging Face + BioNeMo notebooks exist). You can chain it into your full causal pipeline for "DNA edit → RNA change → protein outcome."
This is exactly how researchers are building the "digital twin" layers you described—predicting not just static sequences but dynamic regulatory and translational effects. If you want a concrete code skeleton (e.g., AlphaGenome + translation + AlphaFold in BioNeMo), a diagram of the flow, or focus on one step (e.g., splicing prediction), just say the word and I'll provide it!483ms30 sourcesok let's start with working on the human genome for this prototype, can you create a comprehensive spec for this platform?
 
also this some other research i did for data sources
A gene transcript is a single-stranded RNA molecule produced when a specific segment of DNA (a gene) is copied by an enzyme called RNA polymerase.
While we often think of a gene as a static "blueprint," the transcript is the active "instruction manual" sent to the rest of the cell. As noted in the discussion on Biostars, a single gene can actually produce multiple different transcripts through a process called alternative splicing, where different combinations of coding regions (exons) are joined together.
Key Points about Transcripts:

Composition: They are made of RNA ($  mRNA  $, $  tRNA  $, $  rRNA  $, or non-coding RNA).
Function: Messenger RNA ($  mRNA  $) transcripts carry the genetic code to the ribosome to be translated into proteins.
Diversity: Different transcripts from the same gene allow one gene to create several different protein versions, depending on the tissue or developmental stage.

Where to Find Genomic Locations
To get the exact coordinates (locations) for all human genes and regulatory elements, you should use major genomic "browsers" or databases. These provide GTF or GFF3 files, which are the standard formats for mapping features to the genome.
ResourceBest Used For...EnsemblDetailed gene models, transcript variants, and high-quality "Gold Standard" annotations.UCSC Genome BrowserVisualizing data "tracks" (like H3K27ac marks for enhancers) and downloading bulk data via the Table Browser.GENCODEThe definitive source for human and mouse gene annotations (used by the ENCODE project).ENCODE ProjectThe primary source for regulatory elements (promoters, enhancers, and transcription factor binding sites).
Pro-Tip for your Research
Since you are working on 3D Genome Organization at the Kwan Lab, you might specifically want to look at the Screen registry from ENCODE. It maps millions of "Candidate Cis-Regulatory Elements" ($  ccREs  $) across the human genome, which is essential when analyzing Hi-C data to see how distant enhancers loop to meet their target promoters.
Would you like me to help you find a specific Python script or command to download these coordinate files (like hg38 annotations) for your research?Thought for 18sHuman Genome Digital Twin Prototype (HG-DT v0.1)
Comprehensive System Specification
Version: 1.0 (Prototype)
Date: April 2026
Target: Human genome (GRCh38/hg38)
Primary Goal: Build a modular, research-grade platform that lets you input any DNA edit (SNP, indel, deletion, enhancer/promoter mutation) and predict its effects on:

Regulatory elements & 3D chromatin organization
Transcription (DNA → RNA transcripts, including alternative splicing)
Translation (RNA → protein abundance, isoforms, structure & function)
Cell-type-specific expression changes during differentiation

This directly implements the two systems you described + the 3D DNA organization simulation, while embedding the full DNA → RNA → Protein pipeline.
1. Objectives & Success Criteria

Core Capability: For any genomic coordinate + edit, output before/after predictions with mechanistic explanations (e.g., “deletion disrupts ccRE EH38E1800647 → contact probability ↓42% → expression ↓35% in K562 cells → frameshifted protein with pLDDT drop of 38”).
Research-Grade: Causal (intervention-focused), uncertainty-aware, OOD-evaluable, and interpretable.
Prototype Focus: Start narrow (1–2 cell types: e.g., K562 + GM12878), one 1 Mb locus at a time, then scale.
Usability: Python API + CLI + optional Streamlit web UI for non-coders.
Reproducibility: All data & model calls versioned; outputs include full provenance.

2. Scope & Out-of-Scope (Prototype v0.1)
In Scope:

hg38 reference + GENCODE/ENCODE annotations.
Gene + regulatory element (ccRE) mapping.
AlphaGenome-driven variant effects (accessibility, contact maps, expression, splicing).
Evo 2 as complementary long-context / cross-check model.
DNA → mature mRNA (incl. alternative splicing & isoform prediction).
RNA → protein sequence, abundance, structure (AlphaFold 3), and basic function.
Static + basic dynamic 3D simulation (contact map trajectory across differentiation stages).
Two integrated systems (your exact requests).

Out of Scope (v0.1):

Full-organism or multi-cell-type simulation.
Stochastic single-cell dynamics (use averages + uncertainty).
Wet-lab validation (platform only predicts; user compares to literature/experiments).
Training new foundation models (only fine-tuning/light heads).

3. High-Level Architecture & Data Flow
textCopyINPUT: DNA Edit Specification
   (chrom, start, end, edit_type: SNP/indel/deletion, new_sequence)

          │
          v
[1] REFERENCE CONTEXT BUILDER
   • hg38 FASTA + GENCODE 49 GTF
   • ENCODE Screen cCREs (2.3M elements)
   • Nearby genes, promoters, enhancers, TF motifs
          │
          v
[2] SEQUENCE ENCODER (Dual: Ref + Mutant)
   • AlphaGenome (1 Mb window) → tracks + deltas
   • Evo 2 (long-context fallback) → embeddings
          │
          v
[3] SYSTEM 1: GENE/REGULATOR MAPPING + PROTEIN IMPACT
   • Identify affected gene/transcript(s) → alternative splicing prediction
   • DNA → RNA: new mRNA isoform sequences
   • RNA → Protein: translate + AlphaFold 3 structure/function delta
          │
          v
[4] SYSTEM 2: REGULATORY 3D + EXPRESSION PREDICTION
   • Accessibility Δ + Contact Map Δ (Hi-C style)
   • Regulator scanning (ccREs) → loop strength → expression Δ
          │
          v
[5] 3D DIFFERENTIATION SIMULATOR (Trajectory)
   • Predict contact maps at differentiation time-points
   • Simple dynamics (Neural ODE or linear interpolation + polymer physics)
   • Correlate shape change → expression change
          │
          v
[6] CAUSAL + OUTPUT LAYER
   • Counterfactual deltas, uncertainty (confidence intervals)
   • Mechanistic attribution + visualization (contact maps, structures)
   • JSON + HTML report + optional PDB files
4. Data Sources (Human hg38 – Exact & Ready-to-Use)
All links current as of April 2026:









































LayerResourceFormat / Download LinkSize / NotesReference GenomeUCSC hg38rsync -avzP rsync://hgdownload.soe.ucsc.edu/goldenPath/hg38/bigZips/hg38.fa.gz . or chromFa.tar.gz~3 GBGenes & TranscriptsGENCODE Release 49 (Sept 2025)https://www.gencodegenes.org/human/ → Comprehensive GTF (CHR or ALL)~200 MBRegulatory ElementsENCODE Screen Registry cCREshttps://screen.wenglab.org/downloads → Human GRCh38 (2,348,854 cCREs, 1,888 cell types)~150 MB3D Hi-C / Contact Maps4D Nucleome Data Portalhttps://data.4dnucleome.org/ (uniformly processed Hi-C, GM12878/K562 etc.)Tier 1 reference setsFunctional TracksENCODE + AlphaGenome nativeBuilt-in to AlphaGenome predictionsOn-demand
Python one-liners you can run today:
BashCopy# GENCODE GTF
wget https://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_49/gencode.v49.annotation.gtf.gz

# ENCODE cCREs
wget https://screen.wenglab.org/downloads/GRCh38-cCREs.bed.gz   # or full registry from screen.wenglab.org/downloads
5. ML Models & Pipeline Details
DNA → RNA (Transcription + Splicing)

Primary: AlphaGenome API (free non-commercial) – predicts expression tracks, splice junctions, isoform usage, CAGE signals directly from 1 Mb DNA.
Fallback/Enhancement: Evo 2 (7B/40B via BioNeMo or Hugging Face) for long-range splicing grammar and alternative transcript generation.
Output: Mature mRNA sequence(s) + abundance delta (cell-type specific).

RNA → Protein (Translation)

Deterministic translation: Use Biopython Seq.translate() on predicted mRNA (handles start/stop codons, genetic code).
Efficiency & abundance: RiboNN-style or AlphaGenome-derived expression tracks → protein yield estimate.
Structure & Function: BioNeMo’s AlphaFold 3 / ESMFold → 3D structure (pLDDT scores), domain changes, PPI impact.

3D Organization Simulation

AlphaGenome native contact-map predictions (reference vs. mutant, multiple cell states).
Trajectory: Sample contact maps at “stem → progenitor → differentiated” virtual time points → interpolate with a lightweight Neural ODE or Chrom3D-style polymer model.
Visualization: Before/after Hi-C style heatmaps + loop strength changes correlated to expression.

6. Technical Stack (Prototype-Friendly)

Language: Python 3.11+
Orchestration: BioNeMo (NVIDIA) – already includes Evo 2, AlphaFold 3, Geneformer, accelerated inference.
Models:
AlphaGenome: Official GitHub client (pip install alphagenome) + API key.
Evo 2: NVIDIA NIM or from evo2 import Evo2.

Bioinformatics: PyRanges, pyranges, Biopython, pyfaidx, cooler (Hi-C).
ML/Dynamics: PyTorch, Diffusers (if using diffusion for trajectories).
Visualization: Plotly/Dash for contact maps, NGLview or PyMOL for protein structures, Streamlit UI.
Compute: Local NVIDIA GPU (A100/H100 recommended) or Google Colab Pro / RunPod for AlphaGenome + AlphaFold.

7. Implementation Roadmap & Milestones (8–12 weeks for MVP)
Phase 1 (Week 1–2): Data ingestion + context builder (hg38 + GENCODE + cCREs loader).
Phase 2 (Week 3–4): System 2 MVP – AlphaGenome contact/accessibility/expression pipeline.
Phase 3 (Week 5–6): System 1 MVP – gene/transcript/protein impact (deletion → structure delta).
Phase 4 (Week 7–8): 3D differentiation simulator + causal layer.
Phase 5 (Week 9–10): End-to-end CLI + report generator + basic UI.
Phase 6 (Week 11–12): Validation on known variants (e.g., BRCA1 enhancer deletions) + documentation.
8. Evaluation & Validation Plan

Benchmarks: Held-out eQTLs, ClinVar pathogenic variants, published CRISPRi screens (K562/GM12878).
Metrics: Pearson/Spearman on expression deltas, AUROC on contact changes, pLDDT Δ for proteins, pathway enrichment overlap.
Ground Truth: Compare predictions to published Hi-C, RNA-seq, and proteomics datasets for the same edits.
Uncertainty: Calibrated confidence intervals on every output.

9. Limitations & Future Extensions

Current Limits: AlphaGenome is human/mouse-focused; contact resolution ~2 kb. 3D dynamics are approximated.
v0.2 Ideas: Add single-cell foundation models (scGPT), full Perturb-seq integration, export to virtual cell simulators (PhysiCell + ML layers).

This spec is complete, self-contained, and immediately actionable. It incorporates everything you’ve shared about transcripts, alternative splicing, ENCODE ccREs, and the two systems + 3D simulation.
Next Step Options (tell me which you want first):

Full Python starter repository skeleton (with requirements.txt, data download scripts, and first AlphaGenome + Evo 2 call).
Detailed code for System 2 MVP (contact map + accessibility → expression).
Code for DNA → RNA → Protein end-to-end function.
Streamlit UI mockup or architecture diagram in Mermaid format.

Just say the word and I’ll generate the exact code/files you need to start building today! This prototype is going to be extremely powerful for your Kwan Lab 3D genome work.850ms26 sourcescan you add steps to visualize or understand the products of this system?Thought for 13sYes — excellent request. Visualization and interpretation are critical for turning raw predictions into actionable biological insights (especially in a 3D-genome-focused lab like Kwan Lab). I’ve updated the full Human Genome Digital Twin Prototype (HG-DT v0.1) spec below with a brand-new Section 10: Visualization & Interpretation Layer.
This layer adds concrete, production-ready steps to visualize and understand every product of the system (contact maps, accessibility tracks, expression changes, transcripts, protein structures, 3D trajectories, mechanistic attributions, etc.). I’ve also lightly updated the architecture diagram, technical stack, and roadmap to reference it.
Updated Comprehensive System Specification (v1.1)
Human Genome Digital Twin Prototype (HG-DT v0.1)
Version: 1.1 (with Visualization Layer)
Date: April 2026
Target: Human genome (GRCh38/hg38)
Primary Goal remains unchanged, with the new layer ensuring every output is immediately interpretable and publication-ready.
1–9. (Unchanged from previous spec)
(Reference Context Builder through Causal + Output Layer, Data Sources, ML Models, Technical Stack, Roadmap, Evaluation, Limitations — all identical.)
10. Visualization & Interpretation Layer (New)
Purpose: Make every product of the system visually intuitive, interactive, and biologically meaningful. Users (including non-coders) can instantly compare wild-type vs. mutant, trace causal mechanisms, and generate figures for papers/talks.
Core Outputs to Visualize (tied to System 1, System 2, and 3D simulator):

Regulatory tracks (accessibility, TF binding, histone marks)
Hi-C-style contact maps (before/after + deltas)
Expression & splicing tracks (RNA output)
Protein structures & quality metrics
3D differentiation trajectories (loop formation over time)
Mechanistic attribution (which ccRE/gene drove the effect)
Uncertainty heatmaps & summary reports

Step-by-Step Visualization Pipeline (runs automatically after Step 6):

Genomic Track Browser View (1D linear view)
Tool: pyGenomeTracks (still the gold standard in 2026 — highly customizable, publication-quality).
Inputs: AlphaGenome-predicted bigWig tracks (accessibility, expression, CAGE) + GENCODE genes + ENCODE cCREs.
Output: Side-by-side “Reference vs. Mutant” genome browser plot (with arcs for predicted loops).
Use case: Quickly spot which regulatory element was disrupted and how expression tracks change.

Hi-C Contact Map Explorer (2D 3D-organization view)
Tools:
Cooltools + cooler (core Python libs for loading .cool files from AlphaGenome).
HiCExplorer or FAN-C for triangular heatmaps, loop calls, and differential maps.
HiGlass (web-based, interactive zoomable browser — embeddable in Streamlit).

Outputs:
Before/after contact heatmaps (with delta heatmap overlaid).
Insulation scores, TAD boundaries, and loop strength quantification.
Animated GIF/video of contact map evolution during differentiation (from the 3D simulator).


Protein Structure & Impact Viewer (3D molecular view)
Tools:
NGLview (interactive 3D in Jupyter/Streamlit notebooks — best for quick inspection).
py3Dmol (lightweight, works in Streamlit/Colab).
Optional: Export to PyMOL/ChimeraX for high-res figures.

Outputs:
Side-by-side wild-type vs. mutant structures (colored by pLDDT confidence).
PAE (Predicted Aligned Error) matrices and domain disruption highlights.
Interactive rotation/zoom + distance measurements for key interfaces.


Interactive Dashboard (Unified Understanding Layer)
Tool: Streamlit (fastest for genomics dashboards in 2026 — zero frontend code).
Features:
Upload/edit specification → one-click “Run & Visualize”.
Tabs: Genome Tracks | Contact Maps | 3D Trajectory Animation | Protein Structures | Summary Report.
Sliders for cell-type selection or differentiation time points.
Hover tooltips showing exact deltas (e.g., “Contact probability ↓42% at this loop”).
Download buttons for PNG/PDB/PDF reports.


Mechanistic Interpretation & Attribution
Automatic text + visual summary:
“This deletion removes ccRE EH38E1800647 → weakens enhancer–promoter loop → accessibility ↓28% → isoform switch → truncated protein (pLDDT drop 41)”.

Network graph (via NetworkX + Plotly): affected genes, regulators, and pathways.
Uncertainty visualization: Confidence ribbons on expression tracks + OOD flags.


Implementation Notes:

All viz code is modular (separate visualize.py module) and called at the end of the main pipeline.
Default output: HTML report + folder of PNGs/PDBs/GIFs.
Advanced users can run individual viz steps in notebooks for custom figures.

Updated Architecture Diagram (with Visualization)
textCopy... [6] CAUSAL + OUTPUT LAYER
          │
          v
[10] VISUALIZATION & INTERPRETATION LAYER  ← NEW
   • Genomic tracks (pyGenomeTracks)
   • Contact maps (Cooltools / HiGlass)
   • Protein 3D (NGLview / py3Dmol)
   • Interactive Streamlit dashboard
   • Attribution + animated 3D trajectory
          │
          v
FINAL PRODUCTS: Interactive report + publication figures + mechanistic insights
Updated Technical Stack Additions

Visualization: pyGenomeTracks, cooler + cooltools, HiCExplorer, NGLview, py3Dmol, Streamlit, Plotly.
Dependencies (add to requirements.txt): pygenometracks cooler cooltools nglview py3dmol streamlit plotly networkx.

Updated Roadmap Impact

Phase 5 now includes: “Implement Visualization & Interpretation Layer + Streamlit MVP dashboard”.
Total timeline still ~8–12 weeks; the viz layer can be added in ~1 week once the core predictions exist.

This completes the spec — the platform now not only predicts but also shows you exactly how a DNA edit reshapes regulation, 3D folding, transcription, and proteins.
Ready to build?
Tell me which part you want next and I’ll generate the exact code:

Full starter repo skeleton (with data download + first AlphaGenome call + pyGenomeTracks example).
Complete visualize.py module (contact maps + protein 3D + Streamlit dashboard).
Notebook demo for System 2 (AlphaGenome → contact map viz).

Just say the word — we can have a working visualization prototype running on your machine by the end of the weekend! This will make your Kwan Lab 3D genome work incredibly compelling.490ms30 sources